Harvard Gastroenterology 2024

Inflammatory Bowel Disease and Biologic Therapy

• Updated guidelines for the use of biologics in IBD
• How to choose which biologic agent to start with
• How to monitor patients during IBD treatment
• Role of therapeutic drug monitoring in IBD care
• When to switch therapy and how to approach loss of response
• New agents now available for inflammatory bowel disease
• Management of older adults with IBD and complex comorbidities

Refractory Pouchitis, Microscopic Colitis and Immunotherapy GI Complications

• Managing refractory pouchitis
• Diagnosis and treatment of microscopic colitis
• GI complications of immunotherapy
• Recognition of heterogeneous immune-mediated GI presentations
• Effective treatment strategies for immunotherapy-related GI disease
• Approach to chronic diarrhea and inflammatory mimics
• Practical management strategies for complex IBD-related conditions

C. difficile, Microbiome and Fecal Microbiota Therapy

• Updated guidelines for treatment of C. difficile infection
• When fecal microbiota transplantation is indicated
• The stool microbiome and clinical applications
• Understanding microbiome science behind emerging therapies
• Practical management of recurrent C. difficile
• Antibiotic and non-antibiotic treatment considerations
• Future directions in microbiome-based gastroenterology care

IBS, Fecal Incontinence and Functional GI Disorders

• Improved management of irritable bowel syndrome
• New strategies to treat common GI problems
• Tips for managing fecal incontinence
• Patient-centered approaches to chronic functional GI symptoms
• Differentiating functional symptoms from organic disease
• Practical therapies for symptom control and quality of life improvement
• Applying guideline-based care to common outpatient GI presentations

GERD, Barrett’s Esophagus and Eosinophilic Esophagitis

• Management of refractory GERD
• Barrett’s esophagus updates
• Eosinophilic esophagitis diagnosis and treatment
• Choosing between drug therapy and dietary therapy in eosinophilic esophagitis
• Evaluation of persistent reflux symptoms
• Risk-based management and surveillance strategies
• Practical treatment selection for esophageal disorders

Fatty Liver Disease, Cirrhosis and Alcohol-Related Liver Disease

• Management of fatty liver disease in 2024
• Diagnosis and management of cirrhosis
• Alcohol-related liver disease updates
• Autoimmune hepatitis review
• Risk stratification and monitoring of chronic liver disease
• Practical care strategies for patients with liver disease
• When to refer and how to coordinate multidisciplinary liver care

Pancreatic Disease and Celiac Disease

• Acute pancreatitis evaluation and management
• Chronic pancreatitis updates
• Clinical approach to pancreatic disease in GI practice
• Celiac disease diagnosis and serologic interpretation
• Making sense of multiple celiac serologic tests
• New therapeutic strategies on the horizon for celiac disease
• Practical long-term management of pancreatic and celiac disorders

GI Bleeding and High-Risk Colorectal Cancer

• Techniques to effectively control acute GI bleeding
• Initial stabilization and endoscopic treatment strategies
• Approach to high-risk colorectal cancer patients
• Expanded genetic testing options to diagnose hereditary GI cancer syndromes
• Risk assessment and surveillance planning
• Practical recommendations for hereditary cancer syndrome evaluation
• Improving outcomes through timely detection and appropriate follow-up

Endoscopy Quality and Adenoma Detection Rate

• How to improve adenoma detection rate
• Why adenoma detection rate is critical to measure
• Steps to ensure delivery of high-quality colonoscopic care
• Strategies to improve endoscopy performance
• Use of artificial intelligence to increase adenoma detection rate
• Quality improvement in colonoscopy practice
• Practical systems for better colorectal cancer prevention

Obesity, COVID and Emerging GI Strategies

• Endoscopic management of obesity
• Emerging approaches to obesity treatment in gastroenterology
• Impact of COVID on the GI tract
• New diagnostic and treatment strategies for common GI problems
• Future directions in gastroenterology care
• Inspiring and cutting-edge topics from world-renowned GI experts
• Translating recent advances into practical clinical recommendations

This course is best suited for gastroenterologists, internists, surgeons, nurse practitioners, physician assistants, residents, fellows, primary care physicians, and clinicians involved in GI care.

Topics include IBD, biologic therapies, therapeutic drug monitoring, C. difficile infection, GI complications of immunotherapy, microscopic colitis, fatty liver disease, Barrett’s esophagus, eosinophilic esophagitis, alcohol-related liver disease, autoimmune hepatitis, IBS, refractory GERD, acute pancreatitis, chronic pancreatitis, celiac disease, GI bleeding, high-risk colorectal cancer, adenoma detection rate, colonoscopy quality, endoscopic obesity management, fecal microbiota transplantation, microbiome science, and COVID-related GI effects.

Yes. The course covers updated biologic therapy guidelines, therapeutic drug monitoring, management of older adults with IBD, refractory pouchitis, and treatment optimization strategies.

Yes. The course provides evidence-based recommendations, best practices, updated guidelines, and practical strategies for improving patient outcomes in GI care.

Yes. This product is provided as recorded course access so you can review the material at your own pace.

No. CME credits and certificates are not included with this course package.

You can contact support at support@getmedicalcourses.com.